THERAPEUTIC ROLE OF ANTIOXIDANTS IN LEAD POISONING
抗氧化剂在铅中毒中的治疗作用
基本信息
- 批准号:6224882
- 负责人:
- 金额:$ 11.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-01 至 2002-09-29
- 项目状态:已结题
- 来源:
- 关键词:acetylcysteine antioxidants ascorbate chelating agents chelation therapy diet therapy dietary supplements drug screening /evaluation environmental toxicology laboratory rat lead poisoning nonhuman therapy evaluation nutrition related tag oxidative stress pharmacokinetics short chain fatty acid taurine tocopherols
项目摘要
Despite the fact that 3 million children are affected by lead poisoning each year in the United States, efforts to treat these children and to eliminate lead from the environment have been inadequate. Although chelating agents are currently available for the treatment of lead poisoning, they have been shown to have severe side effects.
Lead poisoning is stated as a multifaceted problem since disruption of a
variety of biochemical processes is responsible for toxicity rather than a
single mechanism. Even though oxidative stress appears to play a major role,
the molecular mechanisms of lead toxicity are not completely known. Our
previous studies demonstrated that treatment with thiols (N-acetylcystein,
alpha-lipoic acid and captopril) significantly reversed lead-induced
alterations in oxidative stress parameters, in both in vivo and in vitro
models. However, none of these antioxidants showed any significant chelating
action for lead. In order to improve the chelating abilities of thiol
antioxidants in the treatment of lead poisoning, we propose to use their
unnatural enantiomers because their natural, biologically-active enantiomers
are quickly metabolized, whereas their unnatural ones are not. This is due to
the fact that enzymes in living systems are usually stereoselective. Therefore,
this continuation of our NIH (1R15ES 09497-01) proposal will explore chelating
actions of the unnatural thiol enantiomers, particularly D-NAC and D-Cysteine
in lead poisoning. This research will produce more effective and safe
therapeutic agents for chelation by exploiting biological dependence on
stereochemistry. In addition, the proposal may offer insights into our
understanding of the mechanisms of enantiomeric selectivity of thiols in
general.
尽管美国每年有300万儿童受到铅中毒的影响,但治疗这些儿童和从环境中消除铅的努力还不够。虽然螯合剂目前可用于治疗铅中毒,但它们已被证明具有严重的副作用。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
N-acetyl-L-cysteine protects against delta-aminolevulinic acid-induced 8-hydroxydeoxyguanosine formation.
N-乙酰基-L-半胱氨酸可防止 δ-氨基乙酰丙酸诱导的 8-羟基脱氧鸟苷形成。
- DOI:10.1016/s0378-4274(99)00014-4
- 发表时间:1999
- 期刊:
- 影响因子:3.5
- 作者:Yusof,M;Yildiz,D;Ercal,N
- 通讯作者:Ercal,N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NURAN ERCAL其他文献
NURAN ERCAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NURAN ERCAL', 18)}}的其他基金
Enhancing ocular uptake of thiol antioxidants with nanodiamonds
用纳米金刚石增强硫醇抗氧化剂的眼部吸收
- 批准号:
9812458 - 财政年份:2019
- 资助金额:
$ 11.1万 - 项目类别:
Therapeutic Effect of a Novel Antioxidant on Degenerative Eye Disorders
新型抗氧化剂对退行性眼部疾病的治疗作用
- 批准号:
8367557 - 财政年份:2012
- 资助金额:
$ 11.1万 - 项目类别:
A New Antioxidant Prevents Toxicity of HIV Proteins with Methamphetamine
一种新的抗氧化剂可防止 HIV 蛋白与甲基苯丙胺的毒性
- 批准号:
7418174 - 财政年份:2007
- 资助金额:
$ 11.1万 - 项目类别:
THERAPEUTIC ROLE OF NATURAL ANTIOXIDANTS IN LEAD POISONI
天然抗氧化剂对铅中毒的治疗作用
- 批准号:
2666546 - 财政年份:1998
- 资助金额:
$ 11.1万 - 项目类别:
THERAPEUTIC ROLE OF N-ACETYLCYSTEINE IN LEAD POISONING
N-乙酰半胱氨酸在铅中毒中的治疗作用
- 批准号:
2157486 - 财政年份:1996
- 资助金额:
$ 11.1万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 11.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 11.1万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 11.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 11.1万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 11.1万 - 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 11.1万 - 项目类别:
Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 11.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 11.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 11.1万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 11.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




